Press Releases
Clarify Health Releases Next-Generation Analytics to Help Pharma and Biotech Commercial Teams Optimize Drug Launches
Clarify Health, a leading healthcare analytics company, announced that its life sciences software, Clarify Launch, now includes innovative enhancements that give brand teams a faster and more effective way to identify market opportunities to drive growth. The ability to...
Clinical Trials
ERT Continues to Drive Innovation in Virtualization for Respiratory Clinical Trials
ERT, the global leader in clinical endpoints data collection, announced a strategic partnership with Inofab Health, a healthcare technology company designing and developing ultrasonic spirometry technology for in-clinic and at-home use. Through the partnership, ERT expands its portfolio of...
Press Releases
Allmpus Laboratories Embraces Local Manufacturing of Pharmaceutical Essentials
Allmpus Laboratories, one of India’s leading research-based pharmaceutical enterprise, is turning to local manufacturing for Pharma essentials. The initiative is taken to localise supply networks and reduce dependency on other countries for raw materials and Active Pharmaceutical Ingredients (APIs)...
Press Releases
Freyr Launches Covid-19 Web Platform for Manufacturers
Freyr, a leading global Regulatory solutions and services company, announces the launch of a powerful web platform for Covid-19 driven with real-time information for manufacturers to make them go to the markets, right in time and support them in...
Clinical Trials
Avalon GloboCare Announces Successful Completion of Phase I Clinical Study of CAR T-Cell Therapy Candidate AVA-001
Avalon GloboCare Corp., a clinical-stage global developer of cell-based technologies and therapeutics, announced it has successfully completed Phase I first-in-human clinical study of its leading Chimeric Antigen Receptor (CAR) T-cell therapy candidate, AVA-001 (National Institute of Health clinical trial...
Press Releases
GSK receives first regulatory approval for Duvroq in Japan for patients with anaemia due to chronic kidney disease
GlaxoSmithKline plc announced the approval of a Japanese New Drug Application (JNDA) by the Ministry of Health, Labour and Welfare for Duvroq (daprodustat) tablets, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), for the treatment of patients with anaemia...
Clinical Trials
Samsung Bioepis Initiates Phase 3 Clinical Trial for SB15, Proposed Biosimilar to Eylea
Samsung Bioepis announced the initiation of Phase 3 clinical trial for SB15, the company's proposed biosimilar referencing Eylea® (aflibercept). The Phase 3 clinical trial for SB15 (aflibercept) is a randomised, double-masked, parallel group, multicenter study to compare the efficacy,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read